Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha...rmaceutical products, including product pricing, the regulatory environment and patent status, which together shape the national hepatitis response in different settings. It highlights key areas for action by ministries of health and other government decision-makers, pharmaceutical manufacturers and technical partners.
more
Модуль из пакета инструментов для оценки потенциала медицинских учреждений в контексте пандемии COVID-19. Временное руководство. 5 февраля 2021 г.
UNAIDS | 2016–2021 Strategy
Accessed: 20.11.2019
Amsterdam, the Netherlands, 23 July 2018
Meeting Report
Endorsed by the CCM Georgia on April 15th 2015
Accessed: 26.09.2019
A Cost-Efficiency Analysis for the Kyrgyz Republi
Midnight, Executive Director
midnightp@apcom.org
Accessed: 27.08.2019
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
The 2016-2017 Biennial report presents an overview of WHO Namibia's main achievements and challenges and highlights its vision for the next five years.
Accelerating HIV prevention to reduce new infections by 75%